Performing diagnostics earlier, less invasively, and more accurately than ever could save untold lives.
For Oliver Loudig, Ph.D., the Center for Discovery and Innovation faculty research working on boundary-pushing tests, he has made it his mission, and vocation, to push the diagnostic “envelope.”
Loudig gave a Hackensack Meridian Health talk “From Tissue to Liquid Biopsies: A Journey Toward Less Invasive and More Precise Diagnostic Biomarkers,” as part of the IHS IPE Research Seminar Series, sponsored by Hackensack Meridian School of Medicine, the Seton Hall University College of Nursing, the Seton Hall University School of Health and Medical Sciences, IHS Student Life, the Hackensack Meridian Health Office of Research Administration, and the Interprofessional Health Sciences Library.
Dr. Loudig provided insights into the use of clinical specimens for detection and identification of small-RNA biomarkers. He described studies performed on archived clinical specimens; the design of a novel assay for purification of circulating biomarkers; and Dr. Loudig also detailed new findings on circulating exosomes from the convalescent plasma of COVID-19 patients.
Dr. Loudig is an associate member at the Center for Discovery and Innovation, where he has been on the faculty since 2018. His work currently focuses on circulating biomarkers, and working closely with clinicians to improve early detection of breast, prostate, and lung cancers.